论文部分内容阅读
肝纤维化是慢性肝炎向肝硬化发展的中间环节，我们发现，联合应用促肝细胞生长素（ＰＨＧＦ）和丹参注射液可有效减缓或逆转慢性肝炎的肝纤维化进程，现将结果报道如下。１ 临床资料 ６８例均系住院患者，男４１例，女２７例，年龄３２～６５岁，平均４１．６岁。肝炎病程１?
Liver fibrosis is an intermediate link between the development of chronic hepatitis and cirrhosis. We found that the combined application of hepatocyte growth-promoting factor (PHGF) and Salvia miltiorrhiza injection can effectively slow down or reverse the progress of liver fibrosis in chronic hepatitis. The results are reported as follows. A clinical data 68 cases were hospitalized patients, 41 males and 27 females, aged 32 to 65 years, mean 41.6 years. Hepatitis course 1?